Rapidly changing landscape of PET/CT imaging in prostate cancer

Abstract

Purpose of review PET/CT imaging in men with prostate cancer (PCa) is rapidly growing as clinicians are becoming aware of its possible fundamental role in the diagnostic flow chart of these patients. As this technology becomes more available worldwide, a considerable number of scientific studies are focusing on specific clinical scenarios and novel PET radiopharmaceuticals that might assist improving early diagnosis and shifting to a truly tailored treatment for PCa. This review focuses on the most recent and important publications in PET/CT imaging of PCa. Recent findings Choline, radiolabelled with either 11-C or 18-F, is now widely used and has shown good performance in detecting sites of..